abstract |
Xylometazolin-containing pharmaceuticals contain 0.001 to 0.5 weight % of a xylometazolin base and 0.00 to 3.00 weight % of etheric oil dissolved in a fatty acid triglyceride having general formula (I), in which x, y and z represent each a number between 5 and 8. |